=
Note: Conversion is based on the latest values and formulas.
Skin Care Regimen Cuts Toxicities of Combo NSCLC Therapy 1 Apr 2025 · A preventative and proactive dermatologic regimen reduces skin and nail adverse reactions in patients with EGFR-mutant NSCLC receiving first-line treatment with …
Evaluation and Management of Small Pulmonary Nodules Lung cancer is the primary etiology of malignant nodules and is the most common cause of cancer-related death in both sexes.
Lung Cancer - Medscape 30 Jun 2025 · Lung Cancer : Review in-depth clinical information, latest medical news, and guidelines on lung cancer, specifically small-cell lung cancer and non-small-cell lung cancer. …
FDA Approves Tarlatamab for Extensive-Stage SCLC - Medscape 16 May 2024 · The US Food and Drug Administration has granted accelerated approval to tarlatamab-dlle (Imdelltra, Amgen) for extensive-stage small cell lung cancer (SCLC) with …
Spinal Cord Compression - Medscape Some tumors, such as Hodgkin's lymphoma and small cell lung cancer, are very sensitive to chemotherapeutic agents, whereas lymphoma and myeloma are more radiosensitive, and …
Fine Particulate Matter Affects EGFR-Mutated Lung Cancers 4 Mar 2024 · Through an epidemiological analysis, the study establishes a dose-dependent association between PM 2.5 exposure and the estimated incidence of EGFR -mutated …
Lung Cancer Screening in the Elderly - Medscape In the past, lung cancer screening in the healthy elderly did not appear cost-effective or reliable, but the situation has changed with the advent of low-dose CT scanning.
Small Cell Lung Cancer in 2024: Treatment Advances - Medscape 19 Mar 2025 · Dr Kris reviews the latest treatment advances in small cell lung cancer, including new standards of care and emerging therapies in 2024.
Solution to "A Forgetful Lung Cancer Patient With Hyponatremia" 10 Apr 2007 · A 70-year-old man with non-small-cell lung cancer presented to the clinic with fatigue and dizziness for 1 month. He complained of weight loss (5-10 pounds) and anorexia, …
Toxicity Linked to Longer Survival in Patients With NSCLC 30 Jan 2024 · Patients who have immune-related adverse events when treated for non–small cell lung cancer (NSCLC) may live longer than those without these complications, according to a …